Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TALAT: Tocopherols and Alpha Lipoic Acid in CKD
NCT00308971Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Mar 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid in chronic kidney disease (CKD), sponsored by Vanderbilt University. Started Mar 2006; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00308971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308971.